Goldman Sachs Downgrades Rating On Johnson & Johnson (JNJ) To “Sell”


Johnson & Johnson (NYSE:JNJ).

On July 21 the stock rating was downgraded to “Sell” from “Neutral” by analysts at BTIG Research. On July 21 the company was downgraded from “Neutral” to “Underweight” in a report from Atlantic Equities.

In the market the company is trading down by 1.29%% since yesterday’s close of 135.22. The company also recently announced a dividend for shareholders that was paid on Tue Jun 13, 2017. The dividend was $0.840 per share for the quarter or $3.36 annualized. This dividend amount represented a yield of $2.50. The ex-dividend date was Friday the 25th of August 2017.

It is trading at $133.48 which is slightly above $132.79, the 50 day moving average and a tad higher than the 200 day moving average of $129.43. The 50 day moving average went up by +0.52% and the 200 day average went up $4.04 or +3.13%.

Johnson & Johnson, launched on November 10, 1887, is a holding company. The Company and its subsidiaries are engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer, Pharmaceutical and Medical Devices. The Business’s primary focus is on products related to human health and well-being. The Business’s subsidiaries operated 119 manufacturing facilities, as of January 1, 2017. The Business’s research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom. The Company has over 230 operating companies, which conduct business around the world..

The company currently has a P/E ratio of 22.59 and market capitalization is 358.26B. As of the last earnings report the EPS was $5.91 and is estimated to be $7.18 for the current year with 2,683,999,000 shares outstanding. Next quarter’s EPS is expected be $1.73 and the next full year EPS is projected to be $7.73.

Short traders are more bearish on Johnson & Johnson recently if you put credence in the increase in short interest. The stock recorded a rise in short interest of 2.35% between August 15, 2017 and August 31, 2017. Short shares grew from 13,449,010 to 13,765,294 over that period. With short interest at 13,765,294 and short average daily volume at 4,995,088, the short-interest ratio is 3.0 and the short interest percentage is 0.01% as of August 31.